Researchers at the Université de Sherbrooke have received a $1.87M grant from the Lotte & John Hetch Memorial Foundation to evaluate the effects of vitamin C for all COVID-19 cases requiring hospitalization. François Lamontagne and Neill Adhikari began their research into the effects of high-dose intravenous vitamin C in 2018, but have since pivoted their research to investigate the potentialities of the vitamin in COVID-19 solutions and treatments. “In light of the current pandemic, we want to evaluate the overall effects of vitamin C on the progression of infections requiring stays in intensive care and on the disease progression in all COVID-19 patients who require hospitalization,” said Lamontagne. “So far, we have recruited 70 COVID-19 patients from across Canada.”